Skip to content

AVIEW RT ACS

by Coreline Soft Co., Ltd.

510(k) K220408

Active European Union and United States

CE MDR CE MDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK220408 Date10 Nov 2022ClearedStatusActive
European UnionCE/MDD EUDAMED Number— Date—StatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive

Official records

From the FDA record

Received by the FDA
14 Feb 2022
FDA decision
10 Nov 2022 (Substantially Equivalent)
FDA review time
269 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K220408 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Across registries

2 registries list this device

  • FDA 510(k) K220408 decided 10 Nov 2022 Active
  • EUDAMED Active· +1 more in the status table

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDD, CE/MDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

510(k) Number
FDA product code
QKB
Device class
Class II
Regulation
21 CFR Part 892.2050
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

AVIEW RT ACS is a radiological image processing software designed for radiation therapy. It automates the segmentation of organs using deep-learning algorithms, generating RT-DICOM formatted contours from CT images. These contours serve as initial reference masks for radiation oncology professionals to review, edit, and integrate into treatment planning workflows. The device aids in streamlining the contouring process for precise radiation therapy delivery.

The AVIEW RT ACS is supplied as a software solution for use in radiation oncology departments. It operates on a non-sterile, reusable digital platform and requires no specific MRI safety considerations. The software is intended for institutional use, with no explicit size or storage requirements beyond standard IT infrastructure. Authorisations include FDA 510(k) clearance, compliance with the Medical Device Directive (MDD), and the Medical Device Regulation (MDR).

Devices cleared under K220408

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K220408
UDI-DISize and differences
AVIEW RT ACS 1.1
CORELINE SOFT CO., LTD.
1.108800025300145 —On the market

Similar devices

Other devices filed under FDA product code QKB (Radiological Image Processing Software For Radiation Therapy).

Other devices from Coreline Soft Co., Ltd.

See all devices from Coreline Soft Co., Ltd. →